https://pharminent.com/sanofi-regeneron-expand-immunology-pact-worth-up-to-8b/ 2026-10-15T11:54:00Z Pharminent en Ultragenyx raises $413M from two priority review voucher sales 2026-10-15T11:45:54Z Blog https://pharminent.com/neuromarket-pulse/neuromarket-pulse-weekly-neuroscience-competitive-intelligence-october-14-2026/ 2026-10-14T23:01:57Z Pharminent en NeuroMarket Pulse • Weekly Neuroscience Competitive Intelligence • October 14, 2026 2026-10-14T23:01:57Z Blog https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-october-14-2026/ 2026-10-14T23:01:31Z Pharminent en Manufacturing Intelligence • Weekly Digest • October 14, 2026 2026-10-14T23:01:31Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-october-13-2026/ 2026-10-14T15:25:23Z Pharminent en Oncology Intelligence Digest • October 13, 2026 2026-10-14T15:25:23Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-october-14-2026/ 2026-10-14T15:25:16Z Pharminent en Strategic News Watch • October 14, 2026 2026-10-14T15:25:16Z Blog https://pharminent.com/roche-licenses-ronas-alk7-targeting-rnai-obesity-drug-in-1b-pact/ 2026-10-14T12:21:07Z Pharminent en J&J raises 2026 guidance as Tremfya drives third-quarter immunology sales 2026-10-14T11:45:48Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-october-12-2026/ 2026-10-13T18:17:22Z Pharminent en Rare Disease & Gene Therapy Digest • October 12, 2026 2026-10-13T18:17:22Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-october-13-2026/ 2026-10-13T15:31:51Z Pharminent en Strategic News Watch • October 13, 2026 2026-10-13T15:31:51Z Blog https://pharminent.com/roche-licenses-ronas-rnai-obesity-program-in-1b-deal/ 2026-10-13T11:45:50Z Pharminent en Roche licenses Rona's RNAi obesity program in $1B deal 2026-10-13T11:45:50Z Blog